Jounce Therapeutics, Inc.
JNCEDelisted May 4, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640455
Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Jounce Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- +1 vs. Q2 2022
- Shares held
- 42.5M
- −122.7K (−0.3%) vs. Q2 2022
- Total value
- $99.5M
- −$29.7M (−23.0%) vs. Q2 2022
- New holders
- 14
- 29 more added
- Sold out
- 13
- 35 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JNCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $917.8K |
| Q1 2023 | 84 | $64.1M |
| Q4 2022 | 85 | $39.8M |
| Q3 2022 | 102 | $99.5M |
| Q2 2022 | 102 | $129.3M |
| Q1 2022 | 113 | $287.1M |
| Q4 2021 | 124 | $342.9M |
| Q3 2021 | 115 | $270.6M |
| Q2 2021 | 130 | $244.8M |
| Q1 2021 | 124 | $378.3M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Jounce Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 4,259,653 | $9.97M | 0.49% | 00.0% | Unchanged |
| RTW Investments, LP | 5,106,341 | $11.9M | 0.28% | +747,908+17.2% | Added |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −981,928−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −82,739−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −52,462−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −39,339−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −37,362−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −36,500−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −34,981−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −20,010−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −18,376−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −11,388−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −660−100.0% | Sold out |
| Frontier Wealth Management LLC | – | – | – | – | Not filed |